Factor V Leiden and hepatic artery thrombosis after liver transplantation
- 14 September 2005
- journal article
- case report
- Published by Wiley in Clinical Transplantation
- Vol. 20 (1), 132-135
- https://doi.org/10.1111/j.1399-0012.2005.00432.x
Abstract
Factor V Leiden (FVL) and other thrombophilias can be acquired during liver transplantation and can have a significant impact on clinical outcomes as well as cost. Standard practice does not include screening deceased donors for heritable thrombophilias, even if they have a personal history of thrombosis. Here we report a case of hepatic artery thrombosis in a liver recipient whose native and donor livers were heterozygous for FVL. The patient subsequently underwent a successful retransplant. FVL and its variants are expressed phenotypically as activated protein C (APC) resistance. We believe that testing liver donors (deceased or living) for APC resistance - a surrogate marker for the most common liver-based thrombophilia - will reduce the incidence of thrombotic events by identifying a need for posttransplant prophylactic anticoagulation in patients at risk. The estimated cost of testing all liver donors in the US for APC resistance is less than the cost of two complications secondary to thrombosis. Testing for APC resistance may further improve outcome and reduce cost after liver transplantation.Keywords
This publication has 20 references indexed in Scilit:
- Infected Bilomas in Liver Transplant Recipients, Incidence, Risk Factors and Implications for PreventionAmerican Journal of Transplantation, 2004
- HEPATIC ARTERY THROMBOSIS AFTER LIVER TRANSPLANTATION AND GENETIC FACTORSTransplantation, 2003
- Arterial complications after liver transplantationTransplant International, 2000
- The influence of clinical variables on hospital costs after orthotopic liver transplantationSurgery, 1999
- Donor factor V leiden mutation and vascular thrombosis following liver transplantationLiver Transplantation and Surgery, 1998
- The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluationJournal of Vascular Surgery, 1997
- ACTIVATED PROTEIN C RESISTANCE DUE TO A COMMON FACTOR V GENE MUTATION IS A MAJOR RISK FACTOR FOR VENOUS THROMBOSISAnnual Review of Medicine, 1997
- HEPATIC ARTERY THROMBOSIS AFTER LIVER TRANSPLANTATION IN CHILDREN UNDER 5 YEARS OF AGETransplantation, 1996
- Phenotypic correction of activated protein C resistance following orthotopic liver transplantationBlood Coagulation & Fibrinolysis, 1996
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994